In this webinar, we demonstrate a use case for characterizing the health of starting donor material in cell therapy manufacturing using the Invitrogen™ Attune™ CytPix™ Flow Cytometer to monitor T-cell ...

The cure for diabetes is a life free from daily insulin injections. Based on that criterion, ten out of 12 people (83%) in a new clinical trial were cured of their diabetes one year after ...

Move over, wrinkle creams—caffeine may hold the key to a longer life.

Spectral flow cytometry is redefining how complex cell populations are analyzed. This guide outlines the most important considerations to run a spectral flow cytometry experiment successfully.

A Canadian woman with type 1 diabetes spent nearly a decade dependent on her glucose monitor and insulin shots — but after a single dose of manufactured stem cells implanted into her liver, she ...

Intercellular fluid flow, not just cell structure, governs how tissues respond to physical forces by Jennifer Chu, Massachusetts Institute of Technology ...

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of ...

Researchers present a new method to safely and preferentially generate CAR T cells directly inside the body using targeted lipid nanoparticles that deliver mRNA directly to T cells. The approach ...

Gene delivery systems can target specific brain cells, a breakthrough that could lead to treatments for Parkinson's, Alzheimer's and other neurodegenerative diseases.

XellSmart's stem cell therapy trial aims to cure spinal cord injuries, offering hope to millions affected worldwide.

KARLSKOGA, Sweden, May 19, 2025 /PRNewswire/ -- Cell Impact AB (publ) has signed an agreement to deliver test tools to a leading industrial player in Asia. The deal confirms Cell Impact's ...

Chimeric antigen receptor (CAR) T cells targeting CD19 have transformed the treatment of B-cell cancers, but many patients do not have long-term remission. We designed an anti-CD19 enhanced (armore ...